25 May 2023 in Toxicological Sciences
The degradation tag (dTAG) system for target protein degradation can remove proteins from biological systems without the drawbacks of some genetic methods, such as slow kinetics, lack of reversibility, low specificity, and the inability to titrate dosage. These drawbacks can make it difficult to compare toxicity resulting from genetic and pharmacological interventions, especially in vivo. Because the dTAG system has not been studied extensively in vivo, we explored the use of this system to study the physiological sequalae resulting from CDK2 or CDK5 degradation in adult mice. Mice with homozygous knock-in of the dTAG sequence onto CDK2 and CDK5 were born at Mendelian ratios despite decreased CDK2 or CDK5 protein levels in comparison with wild-type mice. In bone marrow cells and duodenum organoids derived from these mice, treatment with the dTAG degrader dTAG-13 resulted in rapid and robust protein degradation but caused no appreciable change in viability or the transcriptome. Repeated delivery of dTAG-13 in vivo for toxicity studies proved challenging; we explored multiple formulations in an effort to maximize degradation while minimizing formulation-related toxicity. Degradation of CDK2 or CDK5 in all organs except the brain, where dTAG-13 likely did not cross the blood brain barrier, only caused microscopic changes in the testis of CDK2dTAG mice. These findings were corroborated with conditional CDK2 knockout in adult mice. Our results suggest that the dTAG system can provide robust protein degradation in vivo and that loss of CDK2 or CDK5 in adult mice causes no previously unknown phenotypes.
25 May 2018 in Journal of Histotechnology
Despite the prevalence of hearing loss, there are no FDA-approved chemical entities available for either otoprotection or treatment of hearing impairment. This lack of drug-based treatments has made the assessment of the middle and inner ear a rare, challenging exercise in the pharmaceutical industry. Recently, advances in the use of various decalcifying agents, as well as heating techniques utilizing microwave technology have proven to be effective at shortening processing times, minimizing tissue damage and potentially lowering the cost of histopathological evaluation and diagnosis. This study tested decalcification agents in order to determine the most efficient decalcification procedure for rat outer, middle, and inner ear structures while preserving tissue morphology and eliminating introduction of artifacts to best facilitate histopathological analysis. Presented here are the results of rat ear histological preparations using two decalcifying agents at increasing microwave times with heat controlled at the physiological temperature of 37 °C. In this analysis, an acid-based combination decalcification-fixative solution was found to significantly speed up the decalcification process when compared with the calcium chelator EDTA.